Blood Targets of Adjuvant Drugs Against COVID19.
J Blood Med
; 11: 237-241, 2020.
Article
in English
| MEDLINE | ID: covidwho-680250
ABSTRACT
While waiting for the vaccine and/or the best treatment for COVID19, several drugs have been identified as potential adjuvant drugs to counteract the viral action. Several drugs, in fact, have been suggested for their ancillary antiviral role. Viral proteases and peptidases, may interact with well-known drugs such as anticoagulants, antihypertensives, antiserotoninergics and immunomodulants. We here report a basic list of these drugs that include bioflavonoids, heparinoids, ACE inhibitors, angiotensin receptor blockers, antiserotoninergics, and monoclonal antibodies against cytokines that may interact with the viral cycle.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Vaccines
Language:
English
Journal:
J Blood Med
Year:
2020
Document Type:
Article
Affiliation country:
Jbm.s256121
Similar
MEDLINE
...
LILACS
LIS